Ex parte GREENBERGER - Page 3




              Appeal No. 1996-0927                                                                                        
              Application 07/888,203                                                                                      


                                                    BACKGROUND                                                            

                     At page 4 of the specification, the applicant describes the invention as relating to a               
              method for homing hematopoietic stem cells to bone marrow stromal cells in a host by                        
              administering to a host stromal cells which have been genetically engineered to express a                   
              first member of a ligand-receptor binding pair and hematopoietic stem cells genetically                     
              engineered to express a second member of a ligand-receptor binding pair under                               
              conditions which permit the first member of the ligand-receptor binding pair to bind to the                 
              second member of the ligand-receptor binding pair and thereby resulting in the "homing" of                  
              the stem cells to the stromal cells.  The method is described as being useful for                           
              transplanting bone marrow in a host or for treating a host afflicted with a disease                         
              associated with a disorder of the bone marrow.                                                              
                                                      Discussion:                                                         

                                                  Claim Interpretation:                                                   
                     Claim 22, the sole independent claim, is directed to a method of homing                              
              hematopoietic stem cells to transplanted bone marrow stromal cells and inducing                             
              proliferation of the stem cells in a host, comprising administering to the host both stromal                
              cells which have been genetically engineered to express a first member of a ligand-                         
              receptor binding pair and, subsequently, stem cells which have been genetically                             
              engineered to express a second member of the ligand receptor binding pair.  While not                       


                                                            3                                                             





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007